These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 23890390)

  • 21. Relationship between serum HBV DNA level and HBV-specific, nonspecific cytotoxic T lymphocytes and natural killer cells in patients with chronic hepatitis B.
    Gu XB; Yang XJ; Wang D; Hua Z; Xu YQ; Lu ZH
    Chin Med J (Engl); 2009 Sep; 122(18):2129-32. PubMed ID: 19781297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection.
    Zeng DW; Liu YR; Dong J; Zhu YY; Li YB; Chen J; Zheng Q; Jiang JJ
    Mol Med Rep; 2015 May; 11(5):3465-72. PubMed ID: 25592612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.
    Chung KH; Kim W; Kim BG; Lee HY; Jin E; Cho Y; Seo JY; Kim HY; Jung YJ; Kim JW; Jeong JB; Lee KL
    Gut Liver; 2015 Sep; 9(5):657-64. PubMed ID: 25717049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
    J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients.
    Lin LY; Wong VW; Zhou HJ; Chan HY; Gui HL; Guo SM; Wang H; Huang L; Bao SS; Xie Q; Chan HL
    J Med Virol; 2010 Sep; 82(9):1494-500. PubMed ID: 20648602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional restoration of CD56
    Chen T; Zhu L; Shi A; Ding L; Zhang X; Tan Z; Guo W; Yan W; Han M; Jia J; Luo X; Schuppan D; Ning Q
    Hepatol Int; 2017 Sep; 11(5):419-428. PubMed ID: 28639033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
    Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein.
    Visvanathan K; Skinner NA; Thompson AJ; Riordan SM; Sozzi V; Edwards R; Rodgers S; Kurtovic J; Chang J; Lewin S; Desmond P; Locarnini S
    Hepatology; 2007 Jan; 45(1):102-10. PubMed ID: 17187404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.
    Shen T; Wu WM; Du WH; Wang L; He G; Tan L; Wang Z; Chen R; Hu M; Ren YP
    Lipids Health Dis; 2016 Dec; 15(1):210. PubMed ID: 27927202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between the changes in immune cells and HBeAg loss following antiviral treatment in chronic hepatitis B patients].
    Zheng Q; Zhu YY; Chen J; Liu YR; You J; Zeng DW; Lin S; Jiang JJ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):801-6. PubMed ID: 23206296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
    Bruder Costa J; Dufeu-Duchesne T; Leroy V; Bertucci I; Bouvier-Alias M; Pouget N; Brevot-Lutton O; Bourliere M; Zoulim F; Plumas J; Aspord C;
    PLoS One; 2016; 11(6):e0158297. PubMed ID: 27348813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
    Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBsAg Dampened STING Associated Activation of NK Cells in HBeAg-Negative CHB Patients.
    Zheng B; Yu Y; Pan Z; Feng Y; Zhao H; Han Q; Zhang J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum HBsAg quantification in treatment-naïve Indian patients with chronic hepatitis B.
    Ramachandran J; Ismail AM; Chawla G; Fletcher GJ; Goel A; Eapen CE; Abraham P
    Indian J Gastroenterol; 2014 Mar; 33(2):131-5. PubMed ID: 24052375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B.
    Ratnam DT; Sievert W; Visvanathan K
    Cell Immunol; 2012 Sep; 279(1):109-15. PubMed ID: 23123793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
    Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B.
    Feng Z; Fu J; Tang L; Bao C; Liu H; Liu K; Yang T; Yuan JH; Zhou CB; Zhang C; Xu R; Wang FS
    Hepatol Int; 2024 Aug; 18(4):1122-1134. PubMed ID: 38829576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.